newsfilter
← Latest News
GlobeNewswire·

Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today provided its activity report for the first fiscal